Assessment of urinary N-acetyl-β-glucosaminidase as an early marker of contrast-induced nephropathy

Journal of International Medical Research

Volumn 39, Issue 2, 2011, Pages 647-653

  Ren, L ^a   Ji, J ^a   Fang, Y ^a   Jiang, S H ^a   Lin, Y M ^a   Bo, J ^a   Qian, J Y ^a   Xu, X H ^a   Ding, X Q ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Contrast induced nephropathy; Coronary angiography; Estimated glomerular filtration rate (eGFR); Percutaneous coronary intervention; Urinary N acetyl glucosaminidase

Indexed keywords

CREATININE; N ACETYL BETA GLUCOSAMINIDASE; NONIONIC CONTRAST MEDIUM;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; ENZYMURIA; FEMALE; HIGH RISK PATIENT; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PERCUTANEOUS CORONARY INTERVENTION; SENSITIVITY ANALYSIS; STABLE ANGINA PECTORIS;

EID: 79955669426     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900234     Document Type: Article

References (19)

1. Subramanian S, Tumlin J, Bapat B, et al: Economic burden of contrast-induced nephropathy: implications for prevention strategies. J Med Econ 2007; 10: 119-134.
2. Solomon R: Preventing contrast-induced nephropathy: problems, challenges and future directions. BMC Med 2009; 7: 24.
3. Wong GT, Irwin MG: Contrast-induced nephropathy. Br J Anaesth 2007; 99: 474-483.
4. Heinrich MC, Häberle L, Müller V, et al: Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 2009; 250: 68-86.
5. Wu CT, Sheu ML, Tsai KS, et al: The role of endoplasmic reticulum stress-related unfolded protein response in the radiocontrast mediuminduced renal tubular cell injury. Toxicol Sci 2010; 114: 295-301.
6. Aspelin P, Aubry P, Fransson SG, et al: Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491-499.
7. Grines CL, Schreiber TL, Savas V, et al: A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996; 27: 1381-1386.
8. Clemenzia G, Marvelli M, Sagliaschi G, et al: The evaluation of urinary NAG activity in patients undergoing urography. Minerva Med 1991; 82: 195-200 [in Italian, English abstract].
9. Liangos O, Perianayagam MC, Vaidya VS, et al: Urinary N-acetyl---(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 2007; 18: 904-912.
10. Hosten AO: BUN and creatinine. In: Clinical Methods: The History, Physical, and Laboratory Examinations, 3rd edn (Walker HK, Hall WD, Hurst JW, eds). Boston: Butterworths, 1990; chapter 193, pp 874-878.
11. Johnson CA, Levey AS, Coresh J, et al: Clinical practice guidelines for chronic kidney disease in adults: part II. Glomerular filtration rate, proteinuria, and other markers. Am Fam Physician 2004; 70: 1091-1097.
12. Buyukhatipoglu H, Sezen Y, Yildiz A, et al: NAcetylcysteine fails to prevent renal dysfunction and oxidative stress after noniodine contrast media administration during percutaneous coronary interventions. Pol Arch Med Wewn 2010; 120: 383-389.
13. Calvin AD, Misra S, Pflueger A: Contrastinduced acute kidney injury and diabetic nephropathy. Nat Rev Nephrol 2010; 6: 679-688.
14. Solomon RJ, Natarajan MK, Doucet S, et al: Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized doubleblind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 2007; 115: 3189-3196.
15. Malyszko J: Biomarkers of acute kidney injury in different clinical settings: a time to change the paradigm? Kidney Blood Press Res 2010; 33: 368-382.
16. Berns AS: Nephrotoxicity of contrast media. Kidney Int 1989; 36: 730-740.
17. Price RG: The role of NAG (N-acetyl---Dglucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 1992; 38(suppl 1): S14-S19.
18. Bazzi C, Petrini C, Rizza V, et al: Urinary Nacetyl-a-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 2002; 17: 1890-1896.
19. Westhuyzen J, Endre ZH, Reece G, et al: Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 2003; 18: 543-551.